Ken Saijo

13PUBLICATIONS
28CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer cell biologyCancer geneticsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 27, 2026
First-In-Human Study: Dose Expansion of E7130 in Urothelial Carcinoma and Squamous Cell Carcinoma of the Head and Neck.

|Apr 23, 2026
Inverse Relation Between Responses to Pembrolizumab Plus Chemotherapy and Subsequent Cetuximab Plus Paclitaxel in Head and Neck Cancer: Role of the Janus Kinase-Signal Transducer and Activator of Transcription Signaling Pathway.

|Apr 14, 2026
Clinical Impact of Nivolumab in Sinonasal Mucosal Melanoma: A 14-Year Single-Center Retrospective Study and Comprehensive Literature Review.

Kosuke Terazawa, Ryo Utakata, Ryota Iinuma

|Sep 13, 2025
Immune Checkpoint Inhibitors in Sinonasal Squamous Cell Carcinoma: A Retrospective Study and Literature Review.

Kosuke Terazawa, Masashi Kuroki, Ken Saijo

|Aug 14, 2025
Plasma Lysophosphatidylcholine Levels Correlate with Prognosis and Immunotherapy Response in Squamous Cell Carcinoma.

Tomoyuki Iwasaki, Hidekazu Shirota, Eiji Hishinuma

|Jun 26, 2025
Influence of Citrobacter freundii on NINJ2 Expression and Oxaliplatin Resistance in Colorectal Cancer.

Reio Ueta, Hiroo Imai, Ken Saijo

Pageof 3

Frequent Collaborators

6 joint publications

Chikashi Ishioka

3 joint publications

Masashi Kuroki

3 joint publications

Takenori Ogawa

2 joint publications

Hiroshi Okuda